Dr. Steven K. Herrine, MD

Dr. Herrine practices at Jefferson Nuclear Medicine - HOPD in Philadelphia, Pennsylvania.

Dr. Herrine's NPI, 1366401135, was assigned on March 21, 2006. Dr. Herrine graduated from Jefferson Medical College of Thomas Jefferson University in 1990. Dr. Herrine holds Pennsylvania license MD047858L.

Dr. Herrine's primary practice is Jefferson Nuclear Medicine - HOPD, at 132 South 10th Street, Philadelphia, PA 19107.

Dr. Herrine's primary practice is Jefferson Nuclear Medicine - HOPD in Philadelphia, Pennsylvania. Dr. Herrine is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Herrine to 2 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Herrine's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Herrine practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Herrine's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Herrine is licensed in Pennsylvania.

CMS data shows 127 Medicare services from Dr. Herrine across 3 procedure codes in 2024, all of them office visits, for 120 Medicare patients. Medicare paid $9,141 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 120 Medicare patients who saw Dr. Herrine in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Herrine's median patient age at 65, with 60% women.

In 2024, Dr. Herrine wrote 414 Medicare Part D claims for 81 patients. 78% of them were for generic drugs. CMS names the drug for 274 of them, across 10 drugs with 11 or more claims each, at $111,832 in total drug cost. In 2023, CMS named 256 claims across 12 drugs.

Dr. Herrine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Herrine as offering telehealth.

Dmand AI links 26 papers to Dr. Herrine, published from 2006 to 2025. 2017 was the busiest year, with 2. The most frequent topics are Antiviral Agents, Drug Therapy, Combination and Education, Medical. Dr. Herrine has published most often in Acad Med. Dr. Herrine's most frequent co-authors are Jonathan M. Fenkel, MD, Katherine M. Berg, MD and Jesse Michael Civan, MD.

CMS Open Payments shows 8 general payments to Dr. Herrine from 1 drug or device company from 2016 to 2018. Consulting fees make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $5,330.

Dr. Herrine graduated from Jefferson Medical College of Thomas Jefferson University in 1990.